
About Glasco Pharmaceuticals Private Limited
Data last updated:
Glasco Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24230CH2019PTC042526. Its GSTIN is 04AAHCG8248E1ZN (Chandigarh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Sunil Mishra and Sunny Kumar.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Plot No.901 Phase – 2, Chandigarh, India – 160036.
As per the financials filed for FY 2022, the company reported a revenue of ₹2.32 Cr, a decline of 36% compared to the previous year. For the same year it recorded a net profit of ₹1.96 Cr (net margin 84.8%) and EBITDA of ₹2 Cr (EBITDA margin 86.3%).
As per MCA filings, the company has open charges of ₹35 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
For more details, the company can be reached via its website glascopharmaceuticals.com.
Company details
Contact details
Glasco Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh. Its website is glascopharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.901 Phase – 2, Chandigarh, India – 160036
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Glasco Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Glasco Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Glasco Pharmaceuticals Private Limited, buy the company report.
Financials of Glasco Pharmaceuticals Private Limited
FY 2022 filings availableGlasco Pharmaceuticals Private Limited reported revenue of ₹2.32 Cr (down 36% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 36% in the latest year. EBITDA rose 144% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.96 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 86.3% | ||
| Net Profit Margin | 84.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Glasco Pharmaceuticals Private Limited, buy the company report.
Board of directors of Glasco Pharmaceuticals Private Limited
Glasco Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Mishra | Director | 30 Nov 2021 | 4 Years 11 Months | Current |
| Sunny Kumar | Director | 17 May 2019 | 7 Years 5 Months | Current |
Peer comparison
Glasco Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sargas Meditek Private Limited | ₹2.33 Cr (FY 2022) | 134.0% | Hyderabad, Telangana, India | |||
| Clifford Pharmaceuticals Private Limited | ₹2.32 Cr (FY 2024) | 19.0% | New Delhi, Delhi, India | |||
| Glasco Pharmaceuticals Private Limitedthis company | ₹2.32 Cr (FY 2022) | ₹1.96 Cr | 84.8% | -36.0% | Chandigarh, India | |
| Biosoft Lifesciences Private Limited | ₹2.3 Cr (FY 2025) | -11.0% | Nahan, Himachal Pradesh, India |
To see the full peer comparison of Glasco Pharmaceuticals Private Limited, buy the company report.
Auditor
Glasco Pharmaceuticals Private Limited is audited by TANVI AHUJA AND ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TANVI AHUJA AND ASSOCIATES | FY 2020 | 029520N |
Shareholding
The shareholding of Glasco Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Glasco Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Nov 2020 | 100401939 | Others | ₹35 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Glasco Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ludhiana, Punjab | Commercial suit | Filed against the company by an individual | Disposed |
To see the full case history of Glasco Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glasco Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Glasco Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAHCG8248E1ZN | Chandigarh | Active | 21 Nov 2019 |
| 03AAHCG8248E1ZP | Punjab | Active | 15 Aug 2020 |
To see the full GST registrations and return filing status of Glasco Pharmaceuticals Private Limited, buy the company report.
Recent activity
Glasco Pharmaceuticals Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Rinku Kumari Mishra ceased to be Director on 30 Nov 2021.
Frequently asked questions
Glasco Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 May 2019 (7+ years old) and is registered under CIN U24230CH2019PTC042526.
Glasco Pharmaceuticals has 2 current directors:
- Sunil Mishra - Director
- Sunny Kumar - Director
The latest financial statements of Glasco Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Glasco Pharmaceuticals is 04AAHCG8248E1ZN, registered in Chandigarh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 03AAHCG8248E1ZP (Punjab).
The CIN (Corporate Identification Number) of Glasco Pharmaceuticals is U24230CH2019PTC042526. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glasco Pharmaceuticals has 1 court case on record: 1 filed against it.
Glasco Pharmaceuticals was incorporated on 17 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Glasco Pharmaceuticals by revenue are Sargas Meditek Private Limited, Clifford Pharmaceuticals Private Limited, Biosoft Lifesciences Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Rinku Kumari Mishra ceased to be Director on 30 Nov 2021. Sunil Mishra was appointed as Director on 30 Nov 2021. Shambhu Das ceased to be Director on 11 Nov 2020. Glasco Pharmaceuticals has 5 board changes on record in total.
Glasco Pharmaceuticals can be reached through the website glascopharmaceuticals.com. Its registered office is in Chandigarh, India.
The registered office of Glasco Pharmaceuticals is at Plot No.901 Phase – 2, Chandigarh, India – 160036.

